Search results
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 11 hours agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 8 hours agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 10 hours agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 1 day agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 3 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 18 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 11 hours agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 8 hours agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 13 hours agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 3 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...